ViewRay Stock Forecast, Price & News

ViewRay (NASDAQ:VRAY) Frequently Asked Questions

Is ViewRay a buy right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ViewRay in the last twelve months. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ViewRay stock.
View analyst ratings for ViewRay or view top-rated stocks.

How has ViewRay's stock price been impacted by COVID-19 (Coronavirus)?

ViewRay's stock was trading at $1.69 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, VRAY stock has increased by 249.1% and is now trading at $5.90.
View which stocks have been most impacted by COVID-19.

When is ViewRay's next earnings date?

ViewRay is scheduled to release its next quarterly earnings announcement on Thursday, March 3rd 2022.
View our earnings forecast for ViewRay.

How were ViewRay's earnings last quarter?

ViewRay, Inc. (NASDAQ:VRAY) announced its quarterly earnings data on Thursday, November, 4th. The company reported ($0.15) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.16) by $0.01. The company had revenue of $19.18 million for the quarter, compared to analysts' expectations of $17.05 million. ViewRay had a negative net margin of 159.97% and a negative trailing twelve-month return on equity of 79.12%. The company's quarterly revenue was up 90.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.19) earnings per share.
View ViewRay's earnings history.

What guidance has ViewRay issued on next quarter's earnings?

ViewRay updated its FY 2021 earnings guidance on Thursday, November, 25th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $63 million-$73 million, compared to the consensus revenue estimate of $68.90 million.

What price target have analysts set for VRAY?

5 equities research analysts have issued 12 month target prices for ViewRay's shares. Their forecasts range from $3.00 to $9.00. On average, they anticipate ViewRay's stock price to reach $6.50 in the next twelve months. This suggests a possible upside of 10.2% from the stock's current price.
View analysts' price targets for ViewRay or view top-rated stocks among Wall Street analysts.

Who are ViewRay's key executives?

ViewRay's management team includes the following people:

• Scott William Drake, President, Chief Executive Officer & Director (LinkedIn Profile)
• Zachary Stassen, Chief Financial Officer
• James F. Dempsey, Chief Scientific Officer
• Martin Fuss, Chief Medical Officer
• Robert S. McCormack, Secretary, Senior VP & General Counsel

What is Scott Drake's approval rating as ViewRay's CEO?

5 employees have rated ViewRay CEO Scott Drake on Glassdoor.com. Scott Drake has an approval rating of 59% among ViewRay's employees. This puts Scott Drake in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of ViewRay's key competitors?

Some companies that are related to ViewRay include Outset Medical (OM), BioLife Solutions (BLFS), Natus Medical (NTUS), Cutera (CUTR), TransMedics Group (TMDX), Semler Scientific (SMLR), Stereotaxis (STXS), Zynex (ZYXI), AxoGen (AXGN), Edap Tms (EDAP), Electromed (ELMD), FONAR (FONR), Movano (MOVE), IRIDEX (IRIX) and BioSig Technologies (BSGM).
View all of VRAY's competitors.

What other stocks do shareholders of ViewRay own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ViewRay investors own include Alibaba Group (BABA), Amarin (AMRN), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), Verastem (VSTM), Corbus Pharmaceuticals (CRBP), Viking Therapeutics (VKTX), AbbVie (ABBV), Accuray (ARAY) and Selecta Biosciences (SELB).

When did ViewRay IPO?

(VRAY) raised $52 million in an IPO on the week of April 6th 2015. The company issued 4,000,000 shares at $12.00-$14.00 per share. Cowen and Company and Stifel acted as the underwriters for the IPO and BTIG and Brean Capital were co-managers.

What is ViewRay's stock symbol?

ViewRay trades on the NASDAQ under the ticker symbol "VRAY."

Who are ViewRay's major shareholders?

ViewRay's stock is owned by many different retail and institutional investors. Top institutional investors include Artisan Partners Limited Partnership (14.77%), BlackRock Inc. (5.91%), Bamco Inc. NY (2.67%), Geode Capital Management LLC (1.37%), Millennium Management LLC (1.17%) and Dimensional Fund Advisors LP (1.02%). Company insiders that own ViewRay stock include Influence Ltd Strong, International Ltd Fosun, Scott William Drake and Zachary William Stassen.
View institutional ownership trends for ViewRay.

Which institutional investors are selling ViewRay stock?

VRAY stock was sold by a variety of institutional investors in the last quarter, including Tamarack Advisers LP, Barclays PLC, Morgan Stanley, Panagora Asset Management Inc., Deutsche Bank AG, Caption Management LLC, Goldman Sachs Group Inc., and Telemetry Investments L.L.C.. Company insiders that have sold ViewRay company stock in the last year include Influence Ltd Strong, and International Ltd Fosun.
View insider buying and selling activity for ViewRay or view top insider-selling stocks.

Which institutional investors are buying ViewRay stock?

VRAY stock was purchased by a variety of institutional investors in the last quarter, including Millennium Management LLC, Artisan Partners Limited Partnership, Invesco Ltd., Bamco Inc. NY, Dimensional Fund Advisors LP, Marshall Wace LLP, BlackRock Inc., and Royal Bank of Canada. Company insiders that have bought ViewRay stock in the last two years include Scott William Drake, and Zachary William Stassen.
View insider buying and selling activity for ViewRay or or view top insider-buying stocks.

How do I buy shares of ViewRay?

Shares of VRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ViewRay's stock price today?

One share of VRAY stock can currently be purchased for approximately $5.90.

How much money does ViewRay make?

ViewRay has a market capitalization of $971.98 million and generates $57.02 million in revenue each year. The company earns $-107.91 million in net income (profit) each year or ($0.69) on an earnings per share basis.

How many employees does ViewRay have?

ViewRay employs 236 workers across the globe.

What is ViewRay's official website?

The official website for ViewRay is www.viewray.com.

Where are ViewRay's headquarters?

ViewRay is headquartered at 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH, 44146.

How can I contact ViewRay?

ViewRay's mailing address is 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH, 44146. The company can be reached via phone at (440) 703-3210, via email at [email protected], or via fax at 800-417-3459.